Cargando…

Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study

Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lackner, Sonja, Meier-Allard, Nathalie, Mörkl, Sabrina, Müller, Wolfram, Fürhapter-Rieger, Alfred, Mangge, Harald, Zelzer, Sieglinde, Holasek, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725815/
https://www.ncbi.nlm.nih.gov/pubmed/34992554
http://dx.doi.org/10.3389/fpsyt.2021.758300
_version_ 1784626189339459584
author Lackner, Sonja
Meier-Allard, Nathalie
Mörkl, Sabrina
Müller, Wolfram
Fürhapter-Rieger, Alfred
Mangge, Harald
Zelzer, Sieglinde
Holasek, Sandra
author_facet Lackner, Sonja
Meier-Allard, Nathalie
Mörkl, Sabrina
Müller, Wolfram
Fürhapter-Rieger, Alfred
Mangge, Harald
Zelzer, Sieglinde
Holasek, Sandra
author_sort Lackner, Sonja
collection PubMed
description Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain during the recovery of AN patients. This study evaluated the plasma carotenoid profile and subcutaneous adipose tissue (SAT) in a cohort of AN patients and normal weight (NW) controls. Methods: Plasma concentrations of α-carotene, β-carotene, β-cryptoxanthin, and lycopene were determined by HPLC analysis. SAT thicknesses were measured by a highly accurate and reliable ultrasound technique. Information on dietary intakes were collected by repeated 24-h recalls. Results: Sixty-two females (AN: n = 18, NW: n = 44) were included. The concentrations of β-cryptoxanthin (p = 0.045) and lycopene (p = 0.004) were significantly lower in AN patients. β-carotene levels were higher in AN patients (n.s.) and α-carotene did not differ significantly. SAT thickness was significantly lower in AN patients compared to controls (p < 0.001). β-carotene was significantly negative (r(s) = −0.471) and lycopene significantly positive (r(s) = 0.366) correlated with SAT. The correlation of β-carotene and SAT was even higher in the AN group alone (r(s) = −0.742). Also, β- cryptoxanthin and the sum of provitamin A carotenoids were correlated to SAT (r(s) = −0.647 and r(s) = −0.746, respectively) in AN patients. Fruits and vegetable intake did not differ significantly between AN and NW but adjusted for SAT, AN patients consumed relatively higher amounts (p = 0.006). Conclusion: Higher plasma β-carotene concentrations were associated with reduced SAT levels, most probably due to a reduced ability of the remaining adipose tissue to store carotenoids. Thus, the antiobesity effects of carotenoids might impact the treatment success of undernutrition and AN. A systemic carotenoid overload may contribute to changes in adipogenesis and metabolic capacities for energy storage. Therefore, high plasma β-carotene may be a marker of delay in weight recovery in AN patients. Interventional studies should consider including carotenoid-status in AN treatment.
format Online
Article
Text
id pubmed-8725815
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87258152022-01-05 Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study Lackner, Sonja Meier-Allard, Nathalie Mörkl, Sabrina Müller, Wolfram Fürhapter-Rieger, Alfred Mangge, Harald Zelzer, Sieglinde Holasek, Sandra Front Psychiatry Psychiatry Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain during the recovery of AN patients. This study evaluated the plasma carotenoid profile and subcutaneous adipose tissue (SAT) in a cohort of AN patients and normal weight (NW) controls. Methods: Plasma concentrations of α-carotene, β-carotene, β-cryptoxanthin, and lycopene were determined by HPLC analysis. SAT thicknesses were measured by a highly accurate and reliable ultrasound technique. Information on dietary intakes were collected by repeated 24-h recalls. Results: Sixty-two females (AN: n = 18, NW: n = 44) were included. The concentrations of β-cryptoxanthin (p = 0.045) and lycopene (p = 0.004) were significantly lower in AN patients. β-carotene levels were higher in AN patients (n.s.) and α-carotene did not differ significantly. SAT thickness was significantly lower in AN patients compared to controls (p < 0.001). β-carotene was significantly negative (r(s) = −0.471) and lycopene significantly positive (r(s) = 0.366) correlated with SAT. The correlation of β-carotene and SAT was even higher in the AN group alone (r(s) = −0.742). Also, β- cryptoxanthin and the sum of provitamin A carotenoids were correlated to SAT (r(s) = −0.647 and r(s) = −0.746, respectively) in AN patients. Fruits and vegetable intake did not differ significantly between AN and NW but adjusted for SAT, AN patients consumed relatively higher amounts (p = 0.006). Conclusion: Higher plasma β-carotene concentrations were associated with reduced SAT levels, most probably due to a reduced ability of the remaining adipose tissue to store carotenoids. Thus, the antiobesity effects of carotenoids might impact the treatment success of undernutrition and AN. A systemic carotenoid overload may contribute to changes in adipogenesis and metabolic capacities for energy storage. Therefore, high plasma β-carotene may be a marker of delay in weight recovery in AN patients. Interventional studies should consider including carotenoid-status in AN treatment. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8725815/ /pubmed/34992554 http://dx.doi.org/10.3389/fpsyt.2021.758300 Text en Copyright © 2021 Lackner, Meier-Allard, Mörkl, Müller, Fürhapter-Rieger, Mangge, Zelzer and Holasek. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Lackner, Sonja
Meier-Allard, Nathalie
Mörkl, Sabrina
Müller, Wolfram
Fürhapter-Rieger, Alfred
Mangge, Harald
Zelzer, Sieglinde
Holasek, Sandra
Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title_full Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title_fullStr Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title_full_unstemmed Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title_short Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
title_sort hypercarotenemia in anorexia nervosa patients may influence weight balance: results of a clinical cross-sectional cohort study
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725815/
https://www.ncbi.nlm.nih.gov/pubmed/34992554
http://dx.doi.org/10.3389/fpsyt.2021.758300
work_keys_str_mv AT lacknersonja hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT meierallardnathalie hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT morklsabrina hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT mullerwolfram hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT furhapterriegeralfred hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT manggeharald hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT zelzersieglinde hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy
AT holaseksandra hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy